JAMIE BISEL: Open Payments
NPI 1255692232 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,745 in 167 payments from 23 companies in 2025. Trend: 2023 $2,385 · 2024 $2,340 · 2025 $2,745
Food & beverage: $2,745
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $454 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $304 |
| Novo Nordisk Inc | 19 | $282 |
| AstraZeneca Pharmaceuticals LP | 6 | $247 |
| Corium, LLC | 12 | $199 |
| Axsome Therapeutics, Inc. | 12 | $198 |
| Otsuka America Pharmaceutical, Inc. | 9 | $169 |
| Amgen Inc. | 14 | $166 |
| Lilly USA, LLC | 12 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $83 |
Products named: CAPLYTA, VRAYLAR, Azstarys, Auvelity, REXULTI, FARXIGA, JARDIANCE, Ozempic.
Industry payments across KY — which companies pay providers there.
